The Adobe Flash Player is required to view this multimedia interactive. Get it here.

Clinical trials set for vaccine for H1N1 virus

Third injured firefighter remains at burn unit
3:51 p.m.
Lebanon Police Officer of year inspired by grandfather
2:21 p.m.
Sheriff to target drug trafficking on highways
11:59 a.m.
Ohio can finally collect $2.3M in fines
10:22 a.m.
Top grads plan challenging careers
10:17 a.m.
> More headlines

Staff Report 12:11 PM Friday, July 31, 2009

FRANKLIN — A local research facility will be one of a handful of centers across the country performing clinical trials to test the safety and efficacy of a new vaccine for H1N1 virus, also known as swine flu.

Prestige Clinical Research at 333 Conover Drive Suite D is set to begin human trials mid-month, said Dr. Gary Bedel, principal investigator for Prestige. He said the center would be enrolling candidates for the trial through mid-September.

Bedel said there are two primary groups that will be targeted at the Franklin center: children ages 3 to 9 and adults 65 and older.

“We are trying to get as many people involved as possible,” Bedel said. “These are individuals who have no symptoms, but want to be vaccinated against the flu.”

Bedel says participants will be compensated for their time and travel. He said participants would be tracked for two months after the vaccine is administered to evaluate its effects.

For more information, call Melissa Twine at (937) 746-4505.

Prestige Clinical Research’s clinical trial is sponsored by a confidential agency and is not sponsored by trials funded by the National Institute of Health or any government agency.

Cincinnati Children’s Hospital Medical Center is one of eight centers nationwide chosen by the NIH to test two experimental vaccines for H1N1, also known as swine flu.

Children’s officials expect to begin recruiting volunteers and testing the vaccines in August.

For more information on vaccine studies at Cincinnati Children’s, call (513) 636-7699 or visit gambleprogram@cchmc.org.

Share this article